Sona Nanotech Closes Unbrokered Private Placement Financing for $2.26m in Gross Proceeds
December 16, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...
Sona Nanotech Comments on Market Activity
December 10, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...
Sona Nanotech $2m Private Placement Financing Fully Subscribed
December 3, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...
Sona Nanotech Arranges Private Placement Financing and Appoints EU Agent for Application for CE Mark
December 3, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...
Sona Nanotech Provides Corporate Update
November 30, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid,...
Sona Nanotech Withdraws Rapid COVID-19 Antigen Test Application Based on Feedback from Health Canada
November 25, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid,...
Sona Nanotech appoints new Director
November 3, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA) (the “Company”) is pleased to announce the appointment...
Sona Nanotech Receives ‘Deprioritization’ from FDA; Health Canada Evaluation Continues
October 29, 2020 - Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid, point-of-care diagnostic tests, ...
Is Canada focused on the wrong COVID-19 tests?
There is a growing push to have Canada focus on COVID-19 tests that detect who is contagious rather than who is positive for the virus. These tests are available elsewhere in the world, cheaper and can be done at home, but they aren’t approved in Canada.
Sona Engages Sports Marketing Partner to Secure Concussion Test Development Partner
August 31, 2020 – Halifax, Nova Scotia – Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company”), a developer of rapid,...
Sona Nanotech Announces Clinical Evaluation Study Results for its COVID-19 Antigen Test
August 25, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid, point-of-care...
Sona Nanotech Updates on Timing of Clinical In-Field Validation Studies for its COVID-19 Antigen Test
Halifax, Nova Scotia–(Newsfile Corp. – August 6, 2020) – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer...